<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05790902</url>
  </required_header>
  <id_info>
    <org_study_id>AFIU-2022-02</org_study_id>
    <nct_id>NCT05790902</nct_id>
  </id_info>
  <brief_title>COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI</brief_title>
  <official_title>COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Armed Forces Institute of Urology, Rawalpindi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Armed Forces Institute of Urology, Rawalpindi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of&#xD;
      Distal Ureteric Calculi.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of&#xD;
      Distal Ureteric Calculi in our local setup to find out the optimal drug which promptly and&#xD;
      quickly cures the disease thus enabling the person to return to routine activity with less&#xD;
      adverse effects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2022</start_date>
  <completion_date type="Actual">February 28, 2023</completion_date>
  <primary_completion_date type="Actual">February 28, 2023</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stone clearance rate</measure>
    <time_frame>upto 4 weeks</time_frame>
    <description>Stone clearance rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stone expulsion time</measure>
    <time_frame>upto 4 weeks</time_frame>
    <description>Stone expulsion time</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">142</enrollment>
  <condition>Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi</condition>
  <arm_group>
    <arm_group_label>Silodosin Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients used Silodosin for ureteric calculi</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tamsulosin Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients used Tamsulosin for ureteric calculi</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Silodosin</intervention_name>
    <description>The patients used Silodosin for Medical expulsive therapy of ureteric calculi</description>
    <arm_group_label>Silodosin Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tamsulosin</intervention_name>
    <description>The patients used Tamsulosin for Medical expulsive therapy of ureteric calculi</description>
    <arm_group_label>Tamsulosin Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  symptomatic, unilateral, single, uncomplicated Distal Ureteric Calculi of &lt;10 mm in&#xD;
             size (on plain CT KUB)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  solitary kidney, bilateral ureteric stones, UTI, renal impairment, high-grade&#xD;
             hydronephrosis (Grades 3 and 4), any history of previous endoscopic or surgical&#xD;
             interventions, pregnancy, diabetes mellitus,&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AFIU Rawalpindi</name>
      <address>
        <city>Rawalpindi</city>
        <state>Punjab</state>
        <zip>46000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 17, 2023</study_first_submitted>
  <study_first_submitted_qc>March 17, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2023</study_first_posted>
  <last_update_submitted>March 17, 2023</last_update_submitted>
  <last_update_submitted_qc>March 17, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Armed Forces Institute of Urology, Rawalpindi</investigator_affiliation>
    <investigator_full_name>AJ Arif</investigator_full_name>
    <investigator_title>DR ABDUL JABBAR ARIF</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ureteral Calculi</mesh_term>
    <mesh_term>Ureterolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tamsulosin</mesh_term>
    <mesh_term>Silodosin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

